← board
AVCRF
distress 8/10 · high distress / dilution risk$0.030%today-53% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.3 yrs
Shares 1y
+264%
Price & events
-31.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-29.3%
1W
-22.6%
1M
-29.0%
3M
-31.8%
6M
-49.1%
1Y
-82.2%
2Y
-72.5%
5Y
-54.2%
All
Overview
- Market Cap
- $3.45M
- Volume
- 0
- 52 Week Range
- $0.03 – $0.07
- Total Shares
- 101.29M
- Float Shares
- 93.99M
- % Held by Insiders
- 7.95%
- % Held by Institutions
- 0.00%
- Beta
- 0.32
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-27Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 101,289,664 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-23Why Avricore Health Inc stock is plummeting today - Wealth Awesome
- 2026-07-22Why Avricore Health Inc stock surged yesterday - Wealth Awesome
- 2026-07-21Why Avricore Health Inc stock is skyrocketing today - Wealth Awesome
- 2026-07-17Why Avricore Health Inc stock is plummeting today - Wealth Awesome
- 2026-07-17Enterprise value to EBITDA forward of Avricore Health Inc. – OTC:AVCRF - TradingView
- 2026-07-15Price to earnings forward of Avricore Health Inc. – TSXV:AVCR - TradingView
- 2026-07-14Why Avricore Health Inc stock is plummeting today - Wealth Awesome
- 2026-07-10Avricore Health (OTC: AVCRF) logs $1.254M financing, Mar. 31 results - Stock Titan
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.